About us
About YSK Labs: Shaping Pharmaceutical Innovation
At YSK Labs, we are dedicated to transforming pharmaceutical possibilities. Our focus lies in pioneering “SMART APIs” that bring enhanced value to Active Pharmaceutical Ingredients (APIs) and redefine the realm of formulations. Our Journey Embarking on a journey of innovation, we meticulously research, develop, and manufacture cutting-edge solutions that lay the foundation for superior formulations. Our flagship achievement, the Directly Compressible Granules (DC Granules), marks the first stride in this pursuit, backed by our impressive annual production capacity of 400-500 metric tons of DC Granules.
What are DC Granules?
DC Granules represent a breakthrough semi-formulated state of APIs. These granules revolutionize the formulation process by eliminating the need for granulation and extensive processing. In a single compression step, they seamlessly transform into solid dosage forms (tablets), reshaping the landscape of pharmaceutical manufacturing.
Benefits of DC Granules
By embracing DC Granules, formulators unlock a multitude of
invaluable benefits:
Simplified Manufacturing Process
DC Granules eliminate the need for complex granulation and drying steps, streamlining production into a single compression step.
Cost Efficiency
Reduced processing stages lead to significant cost savings in terms of equipment, energy, and resource utilization.
Time-to-Market Acceleration
The streamlined process speeds up formulation development, allowing products to reach the market faster.
Enhanced Product Quality
DC Granules ensure consistent content uniformity, accurate dosing, and reliable therapeutic outcomes.
Resource Optimization
Fewer processing steps free up production capacities, maximizing resource allocation for other critical aspects.
Innovative Formulation Possibilities
DC Granules enable the creation of novel dosage forms with enhanced solubility, dissolution, and bioavailability.
Regulatory Advantage
The simplified process can lead to quicker regulatory approvals and compliance.
Improved Patient Experience
Smaller tablet sizes achieved with DC Granules enhance patient compliance and ease of administration.
Our
Technical Advantage
At the heart of our operations lies a technical prowess that sets us apart:
Revolutionizing Formulation
Our relentless pursuit of excellence has led to the development of an excellent DC Granule technology.
This innovation transforms the final product (tablet) in meaningful ways.
Enhancing Solubility and Dissolution
Our technology elevates solubility and dissolution performance, driving optimal drug delivery.
Optimizing Tablet Characteristics
We miniaturize tablet sizes, enhancing swallowability, and reducing excipient loads.
Cutting-Edge Production Facility
Complementing our technical prowess, YSK Labs has established a state-of-the-art facility dedicated to producing around 400-500 metric tons of DC Granules annually.
Connect With Us
Experience the future of pharmaceuticals by partnering with YSK Labs. Reach out to us to explore collaborations, innovation, and the seamless fusion of science and progress.
Recognitions
